Inventor · disambiguated record
Panayiotis Alexandrou Procopiou
Also filed as: PROCOPIOU PANAYIOTIS · PROCOPIOU PANAYIOTIS A · PROCOPIOU PANAYIOTIS ALEXANDRO · PROCOPIOU PANAYIOTIS ALEXANDROU
28 granted patents·9 pending applications·201 citations·filing 1986–2018
96Inventor score
Files withGLAXO GROUP LTD23GLAXOSMITHKLINE IP DEV LTD5SMITHKLINE BEECHAM CORP3ANCLIFF RACHAEL ANN1BLAKE KEITH1
Top patents by PatentIndex Score
37 records- 0195US7439393B2Phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2006·Granted Oct 21, 2008·27 cites·22 claims
- 0291US10513517B2Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 24, 2019·11 cites·3 claims
- 0389USRE44874EPhenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2002·Granted Apr 29, 2014·14 cites·30 claims
- 0488US7982067B2Phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2010·Granted Jul 19, 2011·9 cites·21 claims
- 0588US7776895B2Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2008·Granted Aug 17, 2010·7 cites·9 claims
- 0686US7361787B2Phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2002·Granted Apr 22, 2008·17 cites·25 claims
- 0786US7135600B2Phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2002·Granted Nov 14, 2006·18 cites·33 claims
- 0884US10144733B2Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Dec 4, 2018·5 cites·13 claims
- 0984US6197761B117β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivativesGLAXO WELLCOME INC·Filed 1996·Granted Mar 6, 2001·60 cites·27 claims
- 1081US8198483B2Phenethanolamine derivatives for treatment of respiratory diseasesBOX PHILIP CHARLES·Filed 2011·Granted Jun 12, 2012·5 cites·2 claims
- 1178US10487080B2Naphthyridines as integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Nov 26, 2019·3 cites·23 claims
- 1276US10004724B2Compounds alpha v beta 6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jun 26, 2018·2 cites·17 claims
- 1371US7884114B2CompoundsGLAXO GROUP LTD·Filed 2008·Granted Feb 8, 2011·1 cites·18 claims
- 1469US7271197B2Phenethanolamine derivativesGLAXO GROUP LTD·Filed 2003·Granted Sep 18, 2007·4 cites·10 claims
- 1568US7144908B2Agonists of beta-adrenoceptorsGLAXO GROUP LTD·Filed 2002·Granted Dec 5, 2006·4 cites·20 claims
- 1667US7989629B23-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disordersGLAXO GROUP LTD·Filed 2006·Granted Aug 2, 2011·1 cites·16 claims
- 1765US7442839B2Phenethanolamine derivative for the treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2003·Granted Oct 28, 2008·4 cites·22 claims
- 1860US7538127B2Medicinal compoundsGLAXO GROUP LTD·Filed 2004·Granted May 26, 2009·1 cites·36 claims
- 1959US7442837B2Phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2006·Granted Oct 28, 2008·0 cites·16 claims
- 2059US7442836B2Phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2006·Granted Oct 28, 2008·0 cites·15 claims
- 2157US6911560B2Process for preparing salmeterolSMITHKLINE BEECHAM CORP·Filed 2001·Granted Jun 28, 2005·2 cites·10 claims
- 2256US7442719B2Methods using phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2005·Granted Oct 28, 2008·0 cites·29 claims
- 2356US7294725B1Process for preparing salmeterolSMITHKLINE BEECHAM CORP·Filed 2005·Granted Nov 13, 2007·0 cites·6 claims
- 2452US8507543B2CompoundsHODGSON SIMON TEANBY·Filed 2012·Granted Aug 13, 2013·0 cites·4 claims
- 2551US2009105225A12-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 AntagonistsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 2651US2007249630A1Phenethanolamine derivatives for treatment of respiratory diseasesGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 2749US2010216799A1Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonistsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2849US2010222349A1Quinoline derivatives used to treat inflammatory and allergic diseasesGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2948US8357716B2Pyrazole derivatives used as CCR4 receptor antagonistsGLAXO GROUP LTD·Filed 2010·Granted Jan 22, 2013·0 cites·16 claims
- 3045US5112819AImidazole derivatives, pharmaceutical compositions and useGLAXO GROUP LTD·Filed 1990·Granted May 12, 1992·3 cites·13 claims
- 3144US2005070515A1CompoundsSMITHKLINE BEECHAM CORP·Filed 2003·Application pending·0 cites
- 3244US2005209338A1Phenethanolamine derivatives for treatment of respiratory diseasesBLAKE KEITH·Filed 2003·Application pending·0 cites
- 3343US2021206758A1Naphthyridines as integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 3440US2008207638A1CompoundsANCLIFF RACHAEL ANN·Filed 2006·Application pending·0 cites
- 3538US6114318A17β-(2-oxo-tetrahydrofuranyl)-thio- substituted androstane derivativesGLAXO GROUP LTD·Filed 1996·Granted Sep 5, 2000·2 cites·13 claims
- 3630US4837336AProcess for preparing heterocyclic compoundsGLAXO GROUP LTD·Filed 1986·Granted Jun 6, 1989·1 cites·2 claims
- 3723US2002019378A1CompoundsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Panayiotis Alexandrou Procopiou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →